| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 200 | 96 | 9 | 8 | 4 | 4 | 9 | 12 | 4 | 11 | 3 | 3 | 7 | 2 | 5 | 4 | 10 | 5 | 5 | 8 | 9 | 16 | 9 | 7 | 5 | 7 | 3 |
| Expenses | 146 | 79 | 22 | 51 | 44 | 23 | 30 | 34 | 16 | 27 | 28 | 23 | 45 | 29 | 37 | 24 | 25 | 26 | 55 | 34 | 32 | 27 | 49 | 33 | 32 | 55 | 41 |
| EBITDA | 54 | 17 | -13 | -42 | -39 | -19 | -22 | -22 | -12 | -15 | -25 | -20 | -38 | -27 | -32 | -20 | -15 | -22 | -49 | -26 | -22 | -11 | -40 | -26 | -27 | -48 | -38 |
| Operating Profit % | 24 % | 11 % | -936 % | -2,025 % | -2,635 % | -1,517 % | -999 % | -290 % | -994 % | -196 % | -1,764 % | -1,383 % | -2,118 % | -2,341 % | -733 % | -467 % | -595 % | -494 % | -1,720 % | -1,208 % | -737 % | -768 % | -1,885 % | -1,267 % | -3,023 % | -2,032 % | -2,435 % |
| Depreciation | 6 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 47 | 11 | -14 | -44 | -40 | -20 | -23 | -23 | -13 | -17 | -26 | -22 | -39 | -28 | -34 | -21 | -16 | -23 | -51 | -28 | -24 | -13 | -42 | -28 | -28 | -50 | -39 |
| Tax | 21 | 7 | 0 | -4 | -14 | -0 | 0 | 2 | -3 | -1 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Net Profit | 26 | 4 | -14 | -39 | -26 | -20 | -23 | -26 | -11 | -16 | -24 | -22 | -39 | -28 | -34 | -21 | -16 | -23 | -51 | -28 | -24 | -13 | -42 | -27 | -28 | -50 | -39 |
| EPS in ₹ | 2.04 | 0.30 | -1.13 | -3.10 | -2.05 | -1.56 | -1.79 | -2.01 | -0.82 | -1.23 | -1.92 | -1.70 | -3.08 | -2.22 | -2.50 | -1.63 | -1.12 | -1.51 | -2.90 | -1.17 | -1.10 | -0.58 | -1.92 | -1.22 | -1.29 | -2.27 | -1.79 |
Suven Life Sciences
113.38
-4.16
(-3.54%)
Market Cap
2,472.52 Cr
EPS
-4.82
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
169.30
52 Week low
82.95
PB Ratio
13.29
Debt to Equity
0.00
Sector
Healthcare Technology
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 676.60 | 27,235.65 | 57.50 | 3,579.20 | 9.66 | 510 | 17.58 | 37.30 | |
| 522.55 | 12,503.00 | 36.28 | 2,665.90 | 12.77 | 337 | 11.03 | 42.77 | |
| 113.38 | 2,472.52 | - | 32.80 | 49.09 | -105 | 6.46 | 43.87 | |
| 1,044.60 | 2,320.40 | 38.10 | 322.30 | 0.22 | 41 | 112.87 | 60.18 | |
| 63.52 | 149.59 | - | 769.70 | -22.39 | -59 | 17.26 | 52.72 | |
| 8.95 | 132.40 | - | 67.20 | -65.97 | -120 | 2,371.43 | 34.82 | |
| 41.31 | 65.39 | 98.64 | 40.30 | 8.04 | -1 | 120.00 | 42.69 | |
| 16.60 | 26.44 | 33.09 | 80.00 | -3.26 | 2 | -80.00 | 37.84 | |
| 30.00 | 18.98 | - | 9.80 | 40.00 | -9 | -380.00 | 33.72 |
Growth Rate
Revenue Growth
49.09 %
Net Income Growth
-11.16 %
Cash Flow Change
0.44 %
ROE
23.48 %
ROCE
24.98 %
EBITDA Margin (Avg.)
-39.03 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 773 | 752 | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 |
| Fixed Assets | 172 | 305 | 306 | 308 | 22 | 25 | 21 | 38 | 37 | 28 |
| Current Assets | 477 | 428 | 492 | 570 | 281 | 66 | 103 | 67 | 252 | 257 |
| Capital Work in Progress | 107 | 7 | 10 | 25 | 0 | 0 | 5 | 4 | 0 | 0 |
| Investments | 0 | 0 | 301 | 279 | 223 | 0 | 0 | 45 | 46 | 76 |
| Other Assets | 494 | 439 | 199 | 308 | 58 | 157 | 103 | 22 | 305 | 181 |
| Total Liabilities | 773 | 752 | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 |
| Current Liabilities | 127 | 111 | 119 | 122 | 40 | 27 | 16 | 8 | 11 | 14 |
| Non Current Liabilities | 86 | 46 | 30 | 30 | 25 | 12 | 5 | 4 | 3 | 1 |
| Total Equity | 559 | 595 | 667 | 767 | 239 | 143 | 108 | 96 | 375 | 270 |
| Reserve & Surplus | 547 | 583 | 654 | 755 | 226 | 131 | 58 | 82 | 354 | 248 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 15 | 22 | 22 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 212 | -39 | -232 | 17 | -18 | 14 | -5 | -4 | 32 | -22 |
| Investing Activities | -110 | -39 | -311 | -1 | 30 | 146 | 56 | -22 | -248 | 94 |
| Operating Activities | 143 | 68 | 109 | 70 | -53 | -135 | -96 | -128 | -116 | -116 |
| Financing Activities | 179 | -68 | -30 | -52 | 5 | 3 | 35 | 146 | 396 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Nov 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 60.00 % | 60.00 % | 60.00 % | 60.00 % | 64.98 % | 64.98 % | 64.98 % | 64.98 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 70.27 % | 70.27 % | 70.27 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.50 % | 0.54 % | 0.46 % | 0.45 % | 0.34 % | 0.34 % |
| DIIs | 0.21 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.13 % | 0.12 % | 0.11 % | 0.11 % | 0.08 % | 0.01 % | 0.12 % | 1.17 % | 1.17 % | 1.05 % | 1.06 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.92 % | 34.22 % | 33.19 % | 33.24 % | 28.69 % | 29.02 % | 27.37 % | 27.43 % | 22.98 % | 23.00 % | 23.29 % | 24.38 % | 24.05 % | 22.29 % | 22.66 % | 22.15 % | 22.31 % |
| Others | 5.87 % | 5.76 % | 6.79 % | 6.74 % | 6.31 % | 5.98 % | 7.52 % | 7.48 % | 7.34 % | 7.32 % | 7.06 % | 5.54 % | 5.72 % | 6.51 % | 5.46 % | 6.19 % | 6.04 % |
| No of Share Holders | 77,650 | 86,008 | 81,475 | 80,195 | 81,062 | 81,038 | 80,116 | 80,536 | 80,838 | 78,634 | 76,291 | 80,953 | 74,003 | 68,959 | 66,116 | 63,975 | 63,537 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1 | 1.5 | 1.5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 12.85 | 0.57 | 7.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Announcement under Regulation 30 (LODR)-Newspaper Publication
Integrated Filing (Financial)
No Deviation(S) Or Variation(S) In The Use Of Proceeds
Outcome Of The Board Meeting
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended December 31 2024 And Related Matters
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Announcement under Regulation 30 (LODR)-Newspaper Publication
Statement Of Deviation(S) Or Variation(S) For Quarter Ended 30Th September, 2024 Under Regulation 32 Of SEBI (LODR) Regulations, 2015
Outcome Of The Board Meeting - Financial Results For Quarter & Half-Year Ended 30/09/2024
Board Meeting Intimation for Consider And Approve Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Announcement under Regulation 30 (LODR)-Newspaper Publication
Statement Confirming That There Were No Deviation(S) Or Variation(S) In The Use Of Proceeds
Outcome Of The Board Meeting
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Board Meeting Intimation for Board Meeting Of The Company To Be Held On Monday, August 05, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Business Responsibility and Sustainability Reporting (BRSR)
Notice Of 35Th Annual General Meeting (AGM) Of The Company.
Reg. 34 (1) Annual Report.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Closure of Trading Window
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Compliances-Reg.24(A)-Annual Secretarial Compliance
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Announcement under Regulation 30 (LODR)-Newspaper Publication
Statement Of Deviation(S) Or Variation(S) For Quarter Ended 31St March, 2024
E-Annual General Meeting (AGM)
Re-Appointment Of Managing Director
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Grant Of Stock Options By The Nomination & Remuneration Committee Of The Company
Board Meeting Outcome for Outcome Of The Board Meeting
Approved The Attached Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2024
Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Monday, The 06Th May, 2024
Compliance Certificate For The Year Ended 31St March, 2024
Compliance Certificate Under Regulation 40(10) For The Year Ended 31St March, 2024
Company Filings to Exchanges
Jan 2025
Technical Indicators
RSI(14)
Neutral 47.62
ATR(14)
Less Volatile 6.96
STOCH(9,6)
Neutral 76.00
STOCH RSI(14)
Neutral 67.08
MACD(12,26)
Bullish 0.92
ADX(14)
Weak Trend 16.40
UO(9)
Bearish 56.85
ROC(12)
Downtrend And Accelerating -0.77
WillR(14)
Neutral -39.60
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
